Company Overview - Aipeng Medical's closing price on April 3 was 23.56 yuan, down 3.28%, with a rolling PE ratio of 561.71 times and a total market value of 2.97 billion yuan [1] - The company operates in the medical device sector, focusing on pain management and upper respiratory tract management, with key products including microcomputer infusion pumps and wireless pain management systems [1] Financial Performance - For the third quarter of 2024, Aipeng Medical reported revenue of 275 million yuan, a year-on-year decrease of 7.12%, and a net profit of 3.81 million yuan, down 43.99% [2] - The company's gross profit margin stood at 69.02% [2] Market Position - In terms of PE ratio, Aipeng Medical ranks 120th in the medical device industry, which has an average PE of 46.48 times and a median PE of 31.96 times [1][2] - As of the third quarter of 2024, seven institutions held shares in Aipeng Medical, with a total of 755,600 shares valued at 1.3 million yuan [1] Awards and Recognition - The company's brand, Nosqing, received the "West Lake Award: Innovative Marketing" at the Wuzhen Health Conference and was recognized as the "Most Popular Star Product in Pharmacies" for two consecutive years [1] - Nosqing also won the "Most Cooperative Value Product in Chinese Chain Pharmacies" at the 2024 Misi Conference [1]